1-3 of 3
Michael Eby
Close
Sort by
Journal Articles

A Selective PIM Kinase Inhibitor Is Highly Active In Multiple Myeloma: The Biology of Single Agent and PI3K/AKT/mTOR Combination Activity

Allen J. Ebens, PhD, Leanne Berry, Yung-Hsiang Chen, Gauri Deshmukh, Jake Drummond, Changchun Du, Michael Eby, Karen Fitzgerald, Lori S. Friedman, Stephen E. Gould, Jane R. Kenny, Heather Maecker, John Moffat, Marina Moskalenko, Patricia Pacheco, Alham Saadat, Dion Slaga, Laura Sun, Gina Wang, Yagai Yang, Veerendra Munugalavadla, PhD
Journal: Blood
Blood (2010) 116 (21): 3001.
https://doi.org/10.1182/blood.V116.21.3001.3001
Published: 2010
Journal Articles

A Selective PIM Kinase Inhibitor Is Highly Active In Multiple Myeloma: Mechanism of Action and Signal Transduction Studies

Veerendra Munugalavadla, PhD, Leanne Berry, Yung-Hsiang Chen, Gauri Deshmukh, Jake Drummond, Changchun Du, Michael Eby, Karen Fitzgerald, Lori S. Friedman, Stephen E. Gould, Jane R. Kenny, Heather Maecker, John Moffat, Marina Moskalenko, Patricia Pacheco, Alham Saadat, Dion Slaga, Laura Sun, Gina Wang, Yagai Yang, Allen J. Ebens, PhD
Journal: Blood
Blood (2010) 116 (21): 4084.
https://doi.org/10.1182/blood.V116.21.4084.4084
Published: 2010
Journal Articles

Cloning and Characterization of Two Toll/Interleukin-1 Receptor–Like Genes TIL3 and TIL4: Evidence for a Multi-Gene Receptor Family in Humans

Preet M. Chaudhary, Camari Ferguson, Vilaska Nguyen, Oanh Nguyen, Hillary F. Massa, Michael Eby, Alan Jasmin, Barbara J. Trask, Leroy Hood, Peter S. Nelson
Journal: Blood
Blood (1998) 91 (11): 4020–4027.
https://doi.org/10.1182/blood.V91.11.4020
Published: 1998